Stockreport

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH) [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Milestone highlights Merck's focus on global filings to expand access to WINREVAIR and commitment to patients living with PAH RAHWAY, N.J., June 28, 2024 BUSINESS WIR [Read more]